Large Scale FEP on Congeneric Ligand Series Have Practical Free Energy Calculations arrived at Last?

Size: px
Start display at page:

Download "Large Scale FEP on Congeneric Ligand Series Have Practical Free Energy Calculations arrived at Last?"

Transcription

1 Large Scale FEP on Congeneric Ligand Series Have Practical Free Energy Calculations arrived at Last? Thomas Steinbrecher, Teng Lin, Lingle Wang, Goran Krilov, Robert Abel, Woody Sherman, Richard Friesner

2 Large Scale FEP on Congeneric Ligand Series Have Practical Free Energy Calculations arrived at Last? Thomas Steinbrecher, Teng Lin, Lingle Wang, Goran Krilov, Robert Abel, Woody Sherman, Richard Friesner

3 Large Scale FEP on Congeneric Ligand Series Practical Free Energy Calculations at Last! Thomas Steinbrecher, Teng Lin, Lingle Wang, Goran Krilov, Robert Abel, Woody Sherman, Richard Friesner

4 Summary of FEP from Schrödinger We have a robust solution for predicting binding free energies Validation has been performed on over 1000 compounds Mix of retrospective and prospective applications Many target classes covered Kinase Proteases Bromodomains GPCRs PPIs Automated system provides solution for non-fep experts

5 Background: The Drug Design Problem

6 Approved Drugs The Role of Computation Molecular simulations can accelerate discovery Better potency with fewer synthesized compounds Can also account for other properties Selectivity ADME/Tox The Problem Source: FDA

7 Free Energy Simulations Advantages of Free Energy Simulations Based on solid statistical mechanics Takes into account key aspects of binding Dynamics Induced fit Water displacement and interactions Treatment of bound and unbound states Compute true free energies Entropy and enthalpy contributions Have been around for a long time Significant theoretical foundation Many advanced methods available Growing Interest in Protein-Ligand Binding

8 Computational Alchemy: The Abstract λ-coordinate Real starting state Alchemical intermediates Real final state V0 V ( ) V G 0 0 G 0 G 1 G 0 G 0 1 G 0 0 kt ln exp E kt

9 Free Energies from Thermodynamic Cycles Computing relative energies has advantages over absolute energies Smaller perturbations reduces errors Relative changes are of most interest Absolute energies can be trivially obtained once a single experimental binding energy is known To compute the difference in binding of ligand 1 and ligand 2, we can compute the difference between ligand 1 2 in solution and 1 2 in the binding site A 1 2 B G binding = G 1 G 2 = G A G B

10 New Technologies: FEP/REST, OPLS 2.1, Redundancy

11 Several New Technologies Needed for a Robust Solution Improved force field Enhanced sampling Hardware acceleration Automated setup Error estimates OPLS2 REST GPU FEP Mapper Cycle Closure

12 The OPLS2 Force Field Better charges: Semi-empirical charge assignment (CM1A-BCC) More torsional coverage: Parameterization covers > 90% of torsions found in drug-like compounds Automated parameter generation: FFBuilder allows for arbitrary extension of force field coverage Improved results: Excellent results for absolute solvation free energy and relative binding free energy Torsional energy RMSE for 10K molecules Absolute solvation free energies Force Field Slope R 2 OPLS OPLS AM1-BCC/GAFF ChelpG/CHARMM Shivakumar et al., JCTC, 2012, 8 (8),

13 Full Chemical Space Coverage with FFBuilder Coverage prob. per bond (per molecule) Ligand Alignments *MMFF coverage prob based on rel. tr. set size to OPLS2005 MMFF OPLS2005 OPLS2.1 *6% (0%) 25% (0%) 93% (67%) Ligand Alignments Ligand Alignments

14 Full Chemical Space Coverage with FFBuilder Coverage prob. per bond (per molecule) Ligand Alignments *MMFF coverage prob based on rel. tr. set size to OPLS2005 MMFF OPLS2005 OPLS2.1 *6% (0%) 25% (0%) 93% (67%) Ligand Alignments Fill in the Ligand Alignments coverage gap FFBuilder

15 Enhanced Sampling: REST and FEP Thermodynamic axis, alchemical transition λ=0 λ=λ 1 λ=λ m/2 λ=λ m-1 λ=1 T=T 0 T=T 1 T=T h T=T 1 T=T 0 Increasing the temperature of the hot region in intermediate λ Hot Region The ligand and the protein residues surrounding the binding pocket are in the hot region, the rest of the system stay cold. Wang L., Berne B. J., Friesner R.A., PNAS 2012,

16 Representative Configurations Sampled Using FEP/MD vs FEP/REST 1h1q FEP/MD 1h1q FEP/REST 1h1r FEP/MD 1h1r FEP/REST

17 CDK2: 1h1r Multiple Binding Modes Starting Conformation Alternative Conformation Electron Density Method ΔΔG 1H1Q 1H1R FEP FEP/REST 0.14 Expt. 0.51

18 Computation with Graphics Processing Units (GPU) Our standard FEP calculation (one pair of ligands) takes 200 CPU-days! GPUs can make this tractable: 2 perturbations/day on a 4-GPU machine 100 perturbations/day on a 200- GPU machine (what Schrödinger uses) GPU computing is essential! ~100x over CPU GPU ~1000x over CPU ~20,000x over CPU 8-GPU Box 200-GPU Cluster

19 FEP Mapper A human FEP expert will generally Connect molecules with similar R-groups Bias the network to favor high-confidence end states that will become hubs in the network This allows a human expert to run more reliable FEP calculations In FEP Mapper we have automated this highly domain specific expertise

20 Error Estimates from Cycle Closure Compute at least 2 paths for each molecule Closed thermodynamic cycles have ΔΔG=0, thus Any deviation from this provides an error estimate More cycles result in more accurate error estimates Co-crystalized Molecule ΔG 1 Closed Cycle ΔG 3 Assayed Molecule ΔG 2 Idea Molecule ΔG cycle = ΔG 1 +ΔG 2 +ΔG 3 = 0

21 Results and Applications Improved Scoring for Lead Optimization

22 Summary of Results: ~500 Perturbations Target # Ligands R 2 Slope G MUE (kcal/mol) A2A (GPCR) BACE BRD4 (1) BRD4 (2) CDK CHK1 (1) CHK1 (2) HSP JNK Lysozyme MCL MDM MUP-I P PTP1B Throm (1) Throm (2) Mean Unsigned Errors (MUE) 1.0 kcal.mol kcal/mol >1.4 kcal/mol Most errors below 1.0 kcal/mol Accurate for LO Ongoing work to understand outliers

23 Percentage FEP Prediction Accuracy >500 perturbations tested with single protocol RMSE = 1.2 kcal/mol R2 = 0.5 Slope = % 40% 30% 20% 10% 0% 46,2% 24,8% >70% of cases have error 1.2 kcal/mol Distribution of Errors 15,4% Prediction error (kcal/mol) 7,4% 6,2% < >2.4 Target Classes Bromodomains GPCRs Kinases Proteases PPI Others

24 Prediction (kcal/mol) Getting the Physics Right What does a slope of 1 mean? Can compare results between different targets Opens the door for in silico selectivity screening Entropy/enthalpy via in silico van t Hoff Solvation ITC for 220 small molecules Entropy and enthalpy from multiple temperature FEP R 2 = 0.82 ΔG/T DG T ( ) 1 T ( ) = DH 1/T Experiment (kcal/mol)

25 Example Applications

26 G pred kcal/mol Neither MM-GBSA nor WM/MM show strong signal Several species had highly flexible R-groups -7 R 2 = MUE = 0.7 kcal/mol Jnk1 Kinase G exp kcal/mol -8-7

27 MMGBSA Outliers R 2 value for MM-GB/SA scoring is 0.3 over the full set The R 2 value improves to 0.5 with these outliers removed

28 G pred kcal/mol P38 Kinase -10 R 2 =0.64 MUE = 0.9 kcal/mol G exp kcal/mol

29 G pred kcal/mol More P38 Ligands R 2 =0.64 MUE = 0.9 kcal/mol G exp kcal/mol

30 BACE J. N.Cumming et al, Bioorg. Med. Chem. Lett, 22(2012)

31 G pred kcal/mol BACE Correlation -6-7 R 2 =0.59 MUE = 0.9 kcal/mol G exp kcal/mol -8-7

32 Watch out for trapped Water Molecules Red: 4djx, ligand 17h Green: 4djw, ligand 4j

33 Prospective Applications

34 pic50 FEP/REST Prospective Applications for Projects C, D, and E at Schrödinger Most errors below 1.0 kcal/mol Consistent with retrospective results Currently in testing at ~5 pharma sites Results are consistent with our findings Prospective use is ramping up Several manuscripts in preparation Project C Project D pic50 Expt. Project E

35 FEP+ in DDAG 5 DDAG collaborations are heavily using FEP+ 95 prospective FEP+ predictions tested so far 65 predictions were accurate within a log-unit Only 6 were off by more than 2 log-units No dead compounds have been predicted to be tight binding

36 Collaboration B Pyrazole to Thiazole Core-Hop R 1 R 1 N N N R 2 R 3 R 2 R 3 pic 50 = 8.1 pic 50 = 8.3 (within 1 log unit of FEP/REST prediction) New molecule was not scheduled for synthesis prior to FEP calculation New back up series is now being actively developed

37 FEP results are encouraging >1000 perturbations ~20 targets MUE ~1.0 kcal/mol Summary Getting the physics right Correct slope, entropy/enthalpy balance, etc. Many potential applications beyond affinity prediction Selectivity Resistance Fragments Allostery PPIs

38 Development Robert Abel Ed Harder Byungchan Kim Jen Knight Goran Krilov Teng Lin Levi Pierce Lingle Wang Yujie Wu Acknowledgements Applications Thijs Beuming Daniel Cappel Roy Kimura Daniel Robinson Michelle Hall Devleena Shivakumar Thomas Steinbrecher Dora Warshaviak Friesner Lab at Columbia Woody Sherman Management Ramy Farid Rich Friesner Woody Sherman Scientific Advisors Bruce Berne John Chodera Bill Jorgensen David Mobley Mark Murcko Vijay Pande

Accelera'ng Drug Discovery with Free Energy Calcula'ons on GPUs. Robert Abel VP, Scien1fic Development

Accelera'ng Drug Discovery with Free Energy Calcula'ons on GPUs. Robert Abel VP, Scien1fic Development Accelera'ng Drug Discovery with Free Energy Calcula'ons on GPUs Robert Abel VP, Scien1fic Development Drug Discovery It s damned tough to discover a drug. Eugene Cordes The mission of Schrödinger R&D is

More information

Alchemical free energy calculations in OpenMM

Alchemical free energy calculations in OpenMM Alchemical free energy calculations in OpenMM Lee-Ping Wang Stanford Department of Chemistry OpenMM Workshop, Stanford University September 7, 2012 Special thanks to: John Chodera, Morgan Lawrenz Outline

More information

New approaches to scoring function design for protein-ligand binding affinities. Richard A. Friesner Columbia University

New approaches to scoring function design for protein-ligand binding affinities. Richard A. Friesner Columbia University New approaches to scoring function design for protein-ligand binding affinities Richard A. Friesner Columbia University Overview Brief discussion of advantages of empirical scoring approaches Analysis

More information

Thermodynamic Integration with Enhanced Sampling (TIES)

Thermodynamic Integration with Enhanced Sampling (TIES) Thermodynamic Integration with Enhanced Sampling (TIES) A. P. Bhati, S. Wan, D. W. Wright and P. V. Coveney agastya.bhati.14@ucl.ac.uk Centre for Computational Science Department of Chemistry University

More information

Assessment of Water Energe/cs and Applica/ons to Drug Discovery. Daniel D. Robinson

Assessment of Water Energe/cs and Applica/ons to Drug Discovery. Daniel D. Robinson Assessment of Water Energe/cs and Applica/ons to Drug Discovery Daniel D. Robinson Water Energe/cs and Drug Discovery Water is, of course, everywhere Protein binding sites are largely filled with water

More information

MM-GBSA for Calculating Binding Affinity A rank-ordering study for the lead optimization of Fxa and COX-2 inhibitors

MM-GBSA for Calculating Binding Affinity A rank-ordering study for the lead optimization of Fxa and COX-2 inhibitors MM-GBSA for Calculating Binding Affinity A rank-ordering study for the lead optimization of Fxa and COX-2 inhibitors Thomas Steinbrecher Senior Application Scientist Typical Docking Workflow Databases

More information

Structure based drug design and LIE models for GPCRs

Structure based drug design and LIE models for GPCRs Structure based drug design and LIE models for GPCRs Peter Kolb kolb@docking.org Shoichet Lab ACS 237 th National Meeting, March 24, 2009 p.1/26 [Acknowledgements] Brian Shoichet John Irwin Mike Keiser

More information

Large scale free energy calculations for blind predictions of protein ligand binding: the D3R Grand Challenge 2015

Large scale free energy calculations for blind predictions of protein ligand binding: the D3R Grand Challenge 2015 J Comput Aided Mol Des (2016) 30:743 751 DOI 10.1007/s10822-016-9952-x Large scale free energy calculations for blind predictions of protein ligand binding: the D3R Grand Challenge 2015 Nanjie Deng 1 William

More information

Computational chemical biology to address non-traditional drug targets. John Karanicolas

Computational chemical biology to address non-traditional drug targets. John Karanicolas Computational chemical biology to address non-traditional drug targets John Karanicolas Our computational toolbox Structure-based approaches Ligand-based approaches Detailed MD simulations 2D fingerprints

More information

Introduction. OntoChem

Introduction. OntoChem Introduction ntochem Providing drug discovery knowledge & small molecules... Supporting the task of medicinal chemistry Allows selecting best possible small molecule starting point From target to leads

More information

Structure-based maximal affinity model predicts small-molecule druggability

Structure-based maximal affinity model predicts small-molecule druggability Structure-based maximal affinity model predicts small-molecule druggability Alan Cheng alan.cheng@amgen.com IMA Workshop (Jan 17, 2008) Druggability prediction Introduction Affinity model Some results

More information

Conformational Searching using MacroModel and ConfGen. John Shelley Schrödinger Fellow

Conformational Searching using MacroModel and ConfGen. John Shelley Schrödinger Fellow Conformational Searching using MacroModel and ConfGen John Shelley Schrödinger Fellow Overview Types of conformational searching applications MacroModel s conformation generation procedure General features

More information

Synthesis of Variously Functionalized Azabicycloalkane Scaffolds by Domino. Metathesis Reactions

Synthesis of Variously Functionalized Azabicycloalkane Scaffolds by Domino. Metathesis Reactions Supporting Information Synthesis of Variously Functionalized Azabicycloalkane Scaffolds by Domino Metathesis Reactions Massimo Serra*, Elena Giulia Peviani, Eric Bernardi, and Lino Colombo* Department

More information

Early Stages of Drug Discovery in the Pharmaceutical Industry

Early Stages of Drug Discovery in the Pharmaceutical Industry Early Stages of Drug Discovery in the Pharmaceutical Industry Daniel Seeliger / Jan Kriegl, Discovery Research, Boehringer Ingelheim September 29, 2016 Historical Drug Discovery From Accidential Discovery

More information

MD Simulation in Pose Refinement and Scoring Using AMBER Workflows

MD Simulation in Pose Refinement and Scoring Using AMBER Workflows MD Simulation in Pose Refinement and Scoring Using AMBER Workflows Yuan Hu (On behalf of Merck D3R Team) D3R Grand Challenge 2 Webinar Department of Chemistry, Modeling & Informatics Merck Research Laboratories,

More information

Molecular Dynamics Simulations in Drug Discovery. Thomas Fox Discovery Research Boehringer Ingelheim Pharma GmbH & Co KG April 2017

Molecular Dynamics Simulations in Drug Discovery. Thomas Fox Discovery Research Boehringer Ingelheim Pharma GmbH & Co KG April 2017 Molecular Dynamics Simulations in Drug Discovery Thomas Fox Discovery Research Boehringer Ingelheim Pharma GmbH & Co KG April 2017 Boehringer Ingelheim in brief Family-owned global corporation Founded

More information

Drug binding and subtype selectivity in G-protein-coupled receptors

Drug binding and subtype selectivity in G-protein-coupled receptors Drug binding and subtype selectivity in G-protein-coupled receptors Albert C. Pan The Aspect of Time in Drug Design Schloss Rauischholzhausen Marburg, Germany Thursday, March 27 th, 2014 D. E. Shaw Research

More information

FRAGMENT SCREENING IN LEAD DISCOVERY BY WEAK AFFINITY CHROMATOGRAPHY (WAC )

FRAGMENT SCREENING IN LEAD DISCOVERY BY WEAK AFFINITY CHROMATOGRAPHY (WAC ) FRAGMENT SCREENING IN LEAD DISCOVERY BY WEAK AFFINITY CHROMATOGRAPHY (WAC ) SARomics Biostructures AB & Red Glead Discovery AB Medicon Village, Lund, Sweden Fragment-based lead discovery The basic idea:

More information

A critical review of validation, blind testing, and real-world use of alchemical protein-ligand binding free energy calculations

A critical review of validation, blind testing, and real-world use of alchemical protein-ligand binding free energy calculations Journal Name, Year, Volume 1 A critical review of validation, blind testing, and real-world use of alchemical protein-ligand binding free energy calculations Robert Abela*, Lingle Wanga, David L. Mobleyc

More information

SAMPL6 pka Challenge

SAMPL6 pka Challenge SAMPL6 pka Challenge Mehtap Isik Chodera Lab, MSKCC D3R 2018 Workshop February 22nd, 2018 0 Why did we decide to organize a blind pka prediction challenge? SAMPL5 logd challenge indicated the impact of

More information

Hit Finding and Optimization Using BLAZE & FORGE

Hit Finding and Optimization Using BLAZE & FORGE Hit Finding and Optimization Using BLAZE & FORGE Kevin Cusack,* Maria Argiriadi, Eric Breinlinger, Jeremy Edmunds, Michael Hoemann, Michael Friedman, Sami Osman, Raymond Huntley, Thomas Vargo AbbVie, Immunology

More information

D3RGC2: free energy scoring by alchemical free energy implementation in SOMD

D3RGC2: free energy scoring by alchemical free energy implementation in SOMD D3RGC2: free energy scoring by alchemical free energy implementation in SOMD Julien Michel EaStCHEM School of Chemistry, University of Edinburgh, United Kingdom D3R webinar 27/03/17 Acknowledgements: group

More information

User Guide for LeDock

User Guide for LeDock User Guide for LeDock Hongtao Zhao, PhD Email: htzhao@lephar.com Website: www.lephar.com Copyright 2017 Hongtao Zhao. All rights reserved. Introduction LeDock is flexible small-molecule docking software,

More information

The PhilOEsophy. There are only two fundamental molecular descriptors

The PhilOEsophy. There are only two fundamental molecular descriptors The PhilOEsophy There are only two fundamental molecular descriptors Where can we use shape? Virtual screening More effective than 2D Lead-hopping Shape analogues are not graph analogues Molecular alignment

More information

Other Cells. Hormones. Viruses. Toxins. Cell. Bacteria

Other Cells. Hormones. Viruses. Toxins. Cell. Bacteria Other Cells Hormones Viruses Toxins Cell Bacteria ΔH < 0 reaction is exothermic, tells us nothing about the spontaneity of the reaction Δ H > 0 reaction is endothermic, tells us nothing about the spontaneity

More information

Towards Physics-based Models for ADME/Tox. Tyler Day

Towards Physics-based Models for ADME/Tox. Tyler Day Towards Physics-based Models for ADME/Tox Tyler Day Overview Motivation Application: P450 Site of Metabolism Application: Membrane Permeability Future Directions and Applications Motivation Advantages

More information

Molecular Interactions F14NMI. Lecture 4: worked answers to practice questions

Molecular Interactions F14NMI. Lecture 4: worked answers to practice questions Molecular Interactions F14NMI Lecture 4: worked answers to practice questions http://comp.chem.nottingham.ac.uk/teaching/f14nmi jonathan.hirst@nottingham.ac.uk (1) (a) Describe the Monte Carlo algorithm

More information

How is molecular dynamics being used in life sciences? Davide Branduardi

How is molecular dynamics being used in life sciences? Davide Branduardi How is molecular dynamics being used in life sciences? Davide Branduardi davide.branduardi@schrodinger.com Exploring molecular processes with MD Drug discovery and design Protein-protein interactions Protein-DNA

More information

Applications of Fragment Based Approaches

Applications of Fragment Based Approaches Applications of Fragment Based Approaches Ben Davis Vernalis R&D, Cambridge UK b.davis@vernalis.com 1 Applications of Fragment Based Approaches creening fragment libraries Techniques Vernalis eeds approach

More information

Microcalorimetry for the Life Sciences

Microcalorimetry for the Life Sciences Microcalorimetry for the Life Sciences Why Microcalorimetry? Microcalorimetry is universal detector Heat is generated or absorbed in every chemical process In-solution No molecular weight limitations Label-free

More information

Free energy, electrostatics, and the hydrophobic effect

Free energy, electrostatics, and the hydrophobic effect Protein Physics 2016 Lecture 3, January 26 Free energy, electrostatics, and the hydrophobic effect Magnus Andersson magnus.andersson@scilifelab.se Theoretical & Computational Biophysics Recap Protein structure

More information

Structure-Based Drug Discovery An Overview

Structure-Based Drug Discovery An Overview Structure-Based Drug Discovery An Overview Edited by Roderick E. Hubbard University of York, Heslington, York, UK and Vernalis (R&D) Ltd, Abington, Cambridge, UK RSC Publishing Contents Chapter 1 3D Structure

More information

est Drive K20 GPUs! Experience The Acceleration Run Computational Chemistry Codes on Tesla K20 GPU today

est Drive K20 GPUs! Experience The Acceleration Run Computational Chemistry Codes on Tesla K20 GPU today est Drive K20 GPUs! Experience The Acceleration Run Computational Chemistry Codes on Tesla K20 GPU today Sign up for FREE GPU Test Drive on remotely hosted clusters www.nvidia.com/gputestd rive Shape Searching

More information

Schrodinger ebootcamp #3, Summer EXPLORING METHODS FOR CONFORMER SEARCHING Jas Bhachoo, Senior Applications Scientist

Schrodinger ebootcamp #3, Summer EXPLORING METHODS FOR CONFORMER SEARCHING Jas Bhachoo, Senior Applications Scientist Schrodinger ebootcamp #3, Summer 2016 EXPLORING METHODS FOR CONFORMER SEARCHING Jas Bhachoo, Senior Applications Scientist Numerous applications Generating conformations MM Agenda http://www.schrodinger.com/macromodel

More information

Free energy calculations using molecular dynamics simulations. Anna Johansson

Free energy calculations using molecular dynamics simulations. Anna Johansson Free energy calculations using molecular dynamics simulations Anna Johansson 2007-03-13 Outline Introduction to concepts Why is free energy important? Calculating free energy using MD Thermodynamical Integration

More information

Advanced in silico drug design

Advanced in silico drug design Advanced in silico drug design RNDr. Martin Lepšík, Ph.D. Lecture: Advanced scoring Palacky University, Olomouc 2016 1 Outline 1. Scoring Definition, Types 2. Physics-based Scoring: Master Equation Terms

More information

Isothermal Titration Calorimetry in Drug Discovery. Geoff Holdgate Structure & Biophysics, Discovery Sciences, AstraZeneca October 2017

Isothermal Titration Calorimetry in Drug Discovery. Geoff Holdgate Structure & Biophysics, Discovery Sciences, AstraZeneca October 2017 Isothermal Titration Calorimetry in Drug Discovery Geoff Holdgate Structure & Biophysics, Discovery Sciences, AstraZeneca October 217 Introduction Introduction to ITC Strengths / weaknesses & what is required

More information

Kd = koff/kon = [R][L]/[RL]

Kd = koff/kon = [R][L]/[RL] Taller de docking y cribado virtual: Uso de herramientas computacionales en el diseño de fármacos Docking program GLIDE El programa de docking GLIDE Sonsoles Martín-Santamaría Shrödinger is a scientific

More information

Proteins are not rigid structures: Protein dynamics, conformational variability, and thermodynamic stability

Proteins are not rigid structures: Protein dynamics, conformational variability, and thermodynamic stability Proteins are not rigid structures: Protein dynamics, conformational variability, and thermodynamic stability Dr. Andrew Lee UNC School of Pharmacy (Div. Chemical Biology and Medicinal Chemistry) UNC Med

More information

Structural Bioinformatics (C3210) Molecular Docking

Structural Bioinformatics (C3210) Molecular Docking Structural Bioinformatics (C3210) Molecular Docking Molecular Recognition, Molecular Docking Molecular recognition is the ability of biomolecules to recognize other biomolecules and selectively interact

More information

Replica Exchange with Solute Scaling: A More Efficient Version of Replica Exchange with Solute Tempering (REST2)

Replica Exchange with Solute Scaling: A More Efficient Version of Replica Exchange with Solute Tempering (REST2) pubs.acs.org/jpcb Replica Exchange with Solute Scaling: A More Efficient Version of Replica Exchange with Solute Tempering (REST2) Lingle Wang, Richard A. Friesner, and B. J. Berne* Department of Chemistry,

More information

Progress of Compound Library Design Using In-silico Approach for Collaborative Drug Discovery

Progress of Compound Library Design Using In-silico Approach for Collaborative Drug Discovery 21 th /June/2018@CUGM Progress of Compound Library Design Using In-silico Approach for Collaborative Drug Discovery Kaz Ikeda, Ph.D. Keio University Self Introduction Keio University, Tokyo, Japan (Established

More information

Advanced Medicinal Chemistry SLIDES B

Advanced Medicinal Chemistry SLIDES B Advanced Medicinal Chemistry Filippo Minutolo CFU 3 (21 hours) SLIDES B Drug likeness - ADME two contradictory physico-chemical parameters to balance: 1) aqueous solubility 2) lipid membrane permeability

More information

Data Quality Issues That Can Impact Drug Discovery

Data Quality Issues That Can Impact Drug Discovery Data Quality Issues That Can Impact Drug Discovery Sean Ekins 1, Joe Olechno 2 Antony J. Williams 3 1 Collaborations in Chemistry, Fuquay Varina, NC. 2 Labcyte Inc, Sunnyvale, CA. 3 Royal Society of Chemistry,

More information

Gürol M. Süel, Steve W. Lockless, Mark A. Wall, and Rama Ra

Gürol M. Süel, Steve W. Lockless, Mark A. Wall, and Rama Ra Gürol M. Süel, Steve W. Lockless, Mark A. Wall, and Rama Ranganathan, Evolutionarily conserved networks of residues mediate allosteric communication in proteins, Nature Structural Biology, vol. 10, no.

More information

Medicinal Chemist s Relationship with Additivity: Are we Taking the Fundamentals for Granted?

Medicinal Chemist s Relationship with Additivity: Are we Taking the Fundamentals for Granted? Medicinal Chemist s Relationship with Additivity: Are we Taking the Fundamentals for Granted? J. Guy Breitenbucher Streamlining Drug Discovery Conference San Francisco, CA ct. 25, 2018 Additivity as the

More information

Lecture 19: Free Energies in Modern Computational Statistical Thermodynamics: FEP and Related Methods

Lecture 19: Free Energies in Modern Computational Statistical Thermodynamics: FEP and Related Methods Statistical Thermodynamics Lecture 19: Free Energies in Modern Computational Statistical Thermodynamics: FEP and Related Methods Dr. Ronald M. Levy ronlevy@temple.edu Free energy calculations Free energy

More information

Ligand-receptor interactions

Ligand-receptor interactions University of Silesia, Katowice, Poland 11 22 March 2013 Ligand-receptor interactions Dr. Pavel Polishchuk A.V. Bogatsky Physico-Chemical Institute of National Academy of Sciences of Ukraine Odessa, Ukraine

More information

BUDE. A General Purpose Molecular Docking Program Using OpenCL. Richard B Sessions

BUDE. A General Purpose Molecular Docking Program Using OpenCL. Richard B Sessions BUDE A General Purpose Molecular Docking Program Using OpenCL Richard B Sessions 1 The molecular docking problem receptor ligand Proteins typically O(1000) atoms Ligands typically O(100) atoms predicted

More information

György M. Keserű H2020 FRAGNET Network Hungarian Academy of Sciences

György M. Keserű H2020 FRAGNET Network Hungarian Academy of Sciences Fragment based lead discovery - introduction György M. Keserű H2020 FRAGET etwork Hungarian Academy of Sciences www.fragnet.eu Hit discovery from screening Druglike library Fragment library Large molecules

More information

A Large-Scale Test of Free-Energy Simulation Estimates of Protein-Ligand Binding Affinities.

A Large-Scale Test of Free-Energy Simulation Estimates of Protein-Ligand Binding Affinities. A Large-Scale Test of Free-Energy Simulation Estimates of Protein-Ligand Binding Affinities. Mikulskis, Paulius; Genheden, Samuel; Ryde, Ulf Published in: DOI: 10.1021/ci5004027 2014 Link to publication

More information

The importance of protonation and tautomerization in relative binding affinity prediction: a comparison of AMBER TI and Schrödinger FEP

The importance of protonation and tautomerization in relative binding affinity prediction: a comparison of AMBER TI and Schrödinger FEP J Comput Aided Mol Des (2016) 30:533 539 DOI 10.1007/s10822-016-9920-5 The importance of protonation and tautomerization in relative binding affinity prediction: a comparison of AMBER TI and Schrödinger

More information

Enhancing Specificity in the Janus Kinases: A Study on the Thienopyridine. JAK2 Selective Mechanism Combined Molecular Dynamics Simulation

Enhancing Specificity in the Janus Kinases: A Study on the Thienopyridine. JAK2 Selective Mechanism Combined Molecular Dynamics Simulation Electronic Supplementary Material (ESI) for Molecular BioSystems. This journal is The Royal Society of Chemistry 2015 Supporting Information Enhancing Specificity in the Janus Kinases: A Study on the Thienopyridine

More information

Statistical Mechanics for Proteins

Statistical Mechanics for Proteins The Partition Function From Q all relevant thermodynamic properties can be obtained by differentiation of the free energy F: = kt q p E q pd d h T V Q ), ( exp 1! 1 ),, ( 3 3 3 ),, ( ln ),, ( T V Q kt

More information

Ben McFarland Department of Chemistry Seattle Pacific University. Designing Proteins. The Creative Potential of Enthalpy and Entropy

Ben McFarland Department of Chemistry Seattle Pacific University. Designing Proteins. The Creative Potential of Enthalpy and Entropy Ben McFarland Department of Chemistry Seattle Pacific University Designing Proteins The Creative Potential of Enthalpy and Entropy Proteins are chemical: they have defined atomic structures accessible

More information

Using Bayesian Statistics to Predict Water Affinity and Behavior in Protein Binding Sites. J. Andrew Surface

Using Bayesian Statistics to Predict Water Affinity and Behavior in Protein Binding Sites. J. Andrew Surface Using Bayesian Statistics to Predict Water Affinity and Behavior in Protein Binding Sites Introduction J. Andrew Surface Hampden-Sydney College / Virginia Commonwealth University In the past several decades

More information

Life Sciences 1a Lecture Slides Set 10 Fall Prof. David R. Liu. Lecture Readings. Required: Lecture Notes McMurray p , O NH

Life Sciences 1a Lecture Slides Set 10 Fall Prof. David R. Liu. Lecture Readings. Required: Lecture Notes McMurray p , O NH Life ciences 1a Lecture lides et 10 Fall 2006-2007 Prof. David R. Liu Lectures 17-18: The molecular basis of drug-protein binding: IV protease inhibitors 1. Drug development and its impact on IV-infected

More information

Dr. Sander B. Nabuurs. Computational Drug Discovery group Center for Molecular and Biomolecular Informatics Radboud University Medical Centre

Dr. Sander B. Nabuurs. Computational Drug Discovery group Center for Molecular and Biomolecular Informatics Radboud University Medical Centre Dr. Sander B. Nabuurs Computational Drug Discovery group Center for Molecular and Biomolecular Informatics Radboud University Medical Centre The road to new drugs. How to find new hits? High Throughput

More information

Hydrogen Bonding & Molecular Design Peter

Hydrogen Bonding & Molecular Design Peter Hydrogen Bonding & Molecular Design Peter Kenny(pwk.pub.2008@gmail.com) Hydrogen Bonding in Drug Discovery & Development Interactions between drug and water molecules (Solubility, distribution, permeability,

More information

Dispensing Processes Profoundly Impact Biological, Computational and Statistical Analyses

Dispensing Processes Profoundly Impact Biological, Computational and Statistical Analyses Dispensing Processes Profoundly Impact Biological, Computational and Statistical Analyses Sean Ekins 1, Joe Olechno 2 Antony J. Williams 3 1 Collaborations in Chemistry, Fuquay Varina, NC. 2 Labcyte Inc,

More information

Water Networks Contribute to Enthalpy/Entropy Compensation in Protein Ligand Binding

Water Networks Contribute to Enthalpy/Entropy Compensation in Protein Ligand Binding Water Networks Contribute to Enthalpy/Entropy Compensation in Protein Ligand Binding The Harvard community has made this article openly available. Please share how this access benefits you. Your story

More information

= (-22) = +2kJ /mol

= (-22) = +2kJ /mol Lecture 8: Thermodynamics & Protein Stability Assigned reading in Campbell: Chapter 4.4-4.6 Key Terms: DG = -RT lnk eq = DH - TDS Transition Curve, Melting Curve, Tm DH calculation DS calculation van der

More information

Multi-Ensemble Markov Models and TRAM. Fabian Paul 21-Feb-2018

Multi-Ensemble Markov Models and TRAM. Fabian Paul 21-Feb-2018 Multi-Ensemble Markov Models and TRAM Fabian Paul 21-Feb-2018 Outline Free energies Simulation types Boltzmann reweighting Umbrella sampling multi-temperature simulation accelerated MD Analysis methods

More information

Chemogenomic: Approaches to Rational Drug Design. Jonas Skjødt Møller

Chemogenomic: Approaches to Rational Drug Design. Jonas Skjødt Møller Chemogenomic: Approaches to Rational Drug Design Jonas Skjødt Møller Chemogenomic Chemistry Biology Chemical biology Medical chemistry Chemical genetics Chemoinformatics Bioinformatics Chemoproteomics

More information

Pose and affinity prediction by ICM in D3R GC3. Max Totrov Molsoft

Pose and affinity prediction by ICM in D3R GC3. Max Totrov Molsoft Pose and affinity prediction by ICM in D3R GC3 Max Totrov Molsoft Pose prediction method: ICM-dock ICM-dock: - pre-sampling of ligand conformers - multiple trajectory Monte-Carlo with gradient minimization

More information

Supplementary Figures

Supplementary Figures 1 Supplementary Figures Supplementary Figure 1 Type I FGFR1 inhibitors (a) Chemical structures of a pyrazolylaminopyrimidine inhibitor (henceforth referred to as PAPI; PDB-code of the FGFR1-PAPI complex:

More information

Free Energy. because H is negative doesn't mean that G will be negative and just because S is positive doesn't mean that G will be negative.

Free Energy. because H is negative doesn't mean that G will be negative and just because S is positive doesn't mean that G will be negative. Biochemistry 462a Bioenergetics Reading - Lehninger Principles, Chapter 14, pp. 485-512 Practice problems - Chapter 14: 2-8, 10, 12, 13; Physical Chemistry extra problems, free energy problems Free Energy

More information

Protein-Ligand Interactions* and Energy Evaluation Methods

Protein-Ligand Interactions* and Energy Evaluation Methods Protein-Ligand Interactions* and Energy Evaluation Methods *with a revealing look at roles of water Glen E. Kellogg Department of Medicinal Chemistry Institute for Structural Biology, Drug Discovery &

More information

5th CCPN Matt Crump. Thermodynamic quantities derived from protein dynamics

5th CCPN Matt Crump. Thermodynamic quantities derived from protein dynamics 5th CCPN 2005 -Matt Crump Thermodynamic quantities derived from protein dynamics Relaxation in Liquids (briefly!) The fluctuations of each bond vector can be described in terms of an angular correlation

More information

YANK: Free energy calculations made useful.

YANK: Free energy calculations made useful. YANK: Free energy calculations made useful. Kim Branson Vertex Pharmaceuticals John D. Chodera QB3-Berkeley Fellow Vijay Pande Stanford University http://www.choderalab.org SimBios talk - Stanford University

More information

Free energy calculations

Free energy calculations Free energy calculations Jochen Hub & David van der Spoel Overview Free energies and Probabilities Thermodynamic cycles (Free energy perturbation (FEP)) Thermodynamic integration (TI) (Jarzynski equality

More information

Free energy calculations with alchemlyb

Free energy calculations with alchemlyb Free energy calculations with alchemlyb Oliver Beckstein Arizona State University SPIDAL Teleconference 2019-02-01 Binding free energy measure of how strong a protein P and a ligand X stick together key

More information

Virtual Screening: How Are We Doing?

Virtual Screening: How Are We Doing? Virtual Screening: How Are We Doing? Mark E. Snow, James Dunbar, Lakshmi Narasimhan, Jack A. Bikker, Dan Ortwine, Christopher Whitehead, Yiannis Kaznessis, Dave Moreland, Christine Humblet Pfizer Global

More information

Predictive Molecular Simulation for Drug Discovery

Predictive Molecular Simulation for Drug Discovery Predictive Molecular Simulation for Drug Discovery 생명과학 의약연구소의약설계팀이승주 sjlee@lgls.co.kr sjlee.lgls@gmail.com Outline Challenging problems in drug discovery Binding affinity calculation New paradigm for

More information

Presentation Microcalorimetry for Life Science Research

Presentation Microcalorimetry for Life Science Research Presentation Microcalorimetry for Life Science Research MicroCalorimetry The Universal Detector Heat is either generated or absorbed in every chemical process Capable of thermal measurements over a wide

More information

Docking. GBCB 5874: Problem Solving in GBCB

Docking. GBCB 5874: Problem Solving in GBCB Docking Benzamidine Docking to Trypsin Relationship to Drug Design Ligand-based design QSAR Pharmacophore modeling Can be done without 3-D structure of protein Receptor/Structure-based design Molecular

More information

Lecture 2 and 3: Review of forces (ctd.) and elementary statistical mechanics. Contributions to protein stability

Lecture 2 and 3: Review of forces (ctd.) and elementary statistical mechanics. Contributions to protein stability Lecture 2 and 3: Review of forces (ctd.) and elementary statistical mechanics. Contributions to protein stability Part I. Review of forces Covalent bonds Non-covalent Interactions: Van der Waals Interactions

More information

Implementation of novel tools to facilitate fragment-based drug discovery by NMR:

Implementation of novel tools to facilitate fragment-based drug discovery by NMR: Implementation of novel tools to facilitate fragment-based drug discovery by NMR: Automated analysis of large sets of ligand-observed NMR binding data and 19 F methods Andreas Lingel Global Discovery Chemistry

More information

Synthetic organic compounds

Synthetic organic compounds Synthetic organic compounds for research and drug discovery Compounds for TS Fragment libraries Target-focused libraries Chemical building blocks Custom synthesis Drug discovery services Contract research

More information

Role of Desolvation in Thermodynamics and Kinetics of Ligand Binding to a Kinase

Role of Desolvation in Thermodynamics and Kinetics of Ligand Binding to a Kinase pubs.acs.org/jctc Role of Desolvation in Thermodynamics and Kinetics of Ligand Binding to a Kinase Jagannath Mondal, Richard A. Friesner, and B. J. Berne* Department of Chemistry, Columbia University,

More information

Virtual screening for drug discovery. Markus Lill Purdue University

Virtual screening for drug discovery. Markus Lill Purdue University Virtual screening for drug discovery Markus Lill Purdue University mlill@purdue.edu Lecture material http://people.pharmacy.purdue.edu/~mlill/teaching/eidelberg/ I.1 Drug discovery Cl N Disease I.1 Drug

More information

TOPIC 6: Chemical kinetics

TOPIC 6: Chemical kinetics TOPIC 6: Chemical kinetics Reaction rates Reaction rate laws Integrated reaction rate laws Reaction mechanism Kinetic theories Arrhenius law Catalysis Enzimatic catalysis Fuente: Cedre http://loincognito.-iles.wordpress.com/202/04/titanic-

More information

A Brief Guide to All Atom/Coarse Grain Simulations 1.1

A Brief Guide to All Atom/Coarse Grain Simulations 1.1 A Brief Guide to All Atom/Coarse Grain Simulations 1.1 Contents 1. Introduction 2. AACG simulations 2.1. Capabilities and limitations 2.2. AACG commands 2.3. Visualization and analysis 2.4. AACG simulation

More information

Analyzing Molecular Conformations Using the Cambridge Structural Database. Jason Cole Cambridge Crystallographic Data Centre

Analyzing Molecular Conformations Using the Cambridge Structural Database. Jason Cole Cambridge Crystallographic Data Centre Analyzing Molecular Conformations Using the Cambridge Structural Database Jason Cole Cambridge Crystallographic Data Centre 1 The Cambridge Structural Database (CSD) 905,284* USOPEZ a natural product intermediate,

More information

Kinome-wide Activity Models from Diverse High-Quality Datasets

Kinome-wide Activity Models from Diverse High-Quality Datasets Kinome-wide Activity Models from Diverse High-Quality Datasets Stephan C. Schürer*,1 and Steven M. Muskal 2 1 Department of Molecular and Cellular Pharmacology, Miller School of Medicine and Center for

More information

Scoring functions for of protein-ligand docking: New routes towards old goals

Scoring functions for of protein-ligand docking: New routes towards old goals 3nd Strasbourg Summer School on Chemoinformatics Strasbourg, June 25-29, 2012 Scoring functions for of protein-ligand docking: New routes towards old goals Christoph Sotriffer Institute of Pharmacy and

More information

Machine learning for ligand-based virtual screening and chemogenomics!

Machine learning for ligand-based virtual screening and chemogenomics! Machine learning for ligand-based virtual screening and chemogenomics! Jean-Philippe Vert Institut Curie - INSERM U900 - Mines ParisTech In silico discovery of molecular probes and drug-like compounds:

More information

GC and CELPP: Workflows and Insights

GC and CELPP: Workflows and Insights GC and CELPP: Workflows and Insights Xianjin Xu, Zhiwei Ma, Rui Duan, Xiaoqin Zou Dalton Cardiovascular Research Center, Department of Physics and Astronomy, Department of Biochemistry, & Informatics Institute

More information

Protein Folding experiments and theory

Protein Folding experiments and theory Protein Folding experiments and theory 1, 2,and 3 Protein Structure Fig. 3-16 from Lehninger Biochemistry, 4 th ed. The 3D structure is not encoded at the single aa level Hydrogen Bonding Shared H atom

More information

Lots of thanks for many reasons!

Lots of thanks for many reasons! Lots of thanks for many reasons! Structure and function of glutamate transporters from free energy simulations Turgut Baştuğ TOBB ETU Transporter structures Transporters have larger structures, which

More information

Fragment Hotspot Maps: A CSD-derived Method for Hotspot identification

Fragment Hotspot Maps: A CSD-derived Method for Hotspot identification Fragment Hotspot Maps: A CSD-derived Method for Hotspot identification Chris Radoux www.ccdc.cam.ac.uk radoux@ccdc.cam.ac.uk 1 Introduction Hotspots Strongly attractive to organic molecules Organic molecules

More information

Quantification of free ligand conformational preferences by NMR and their relationship to the bioactive conformation

Quantification of free ligand conformational preferences by NMR and their relationship to the bioactive conformation Quantification of free ligand conformational preferences by NMR and their relationship to the bioactive conformation Charles Blundell charles.blundell@c4xdiscovery.com www.c4xdiscovery.com Rigid: single

More information

Receptor Based Drug Design (1)

Receptor Based Drug Design (1) Induced Fit Model For more than 100 years, the behaviour of enzymes had been explained by the "lock-and-key" mechanism developed by pioneering German chemist Emil Fischer. Fischer thought that the chemicals

More information

1 What is energy?

1 What is energy? http://www.intothecool.com/ 1 What is energy? the capacity to do work? (Greek: en-, in; + ergon, work) the capacity to cause change to produce an effect? a certain quantity that does not change in the

More information

Using AutoDock for Virtual Screening

Using AutoDock for Virtual Screening Using AutoDock for Virtual Screening CUHK Croucher ASI Workshop 2011 Stefano Forli, PhD Prof. Arthur J. Olson, Ph.D Molecular Graphics Lab Screening and Virtual Screening The ultimate tool for identifying

More information

Toward an Understanding of GPCR-ligand Interactions. Alexander Heifetz

Toward an Understanding of GPCR-ligand Interactions. Alexander Heifetz Toward an Understanding of GPCR-ligand Interactions Alexander Heifetz UK QSAR and ChemoInformatics Group Conference, Cambridge, UK October 6 th, 2015 Agenda Fragment Molecular Orbitals (FMO) for GPCR exploration

More information

*Corresponding Author *K. F.: *T. H.:

*Corresponding Author *K. F.:   *T. H.: Theoretical Analysis of Activity Cliffs among Benzofuranone Class Pim1 Inhibitors Using the Fragment Molecular Orbital Method with Molecular Mechanics Poisson-Boltzmann Surface Area (FMO+MM-PBSA) Approach

More information

Biological Thermodynamics

Biological Thermodynamics Biological Thermodynamics Classical thermodynamics is the only physical theory of universal content concerning which I am convinced that, within the framework of applicability of its basic contents, will

More information

Entropy-Enthalpy Compensation: Role and Ramifications in Biomolecular Ligand Recognition and Design

Entropy-Enthalpy Compensation: Role and Ramifications in Biomolecular Ligand Recognition and Design Annu. Rev. Biophys. 213. 42:121 42 The Annual Review of Biophysics is online at biophys.annualreviews.org This article s doi: 1.1146/annurev-biophys-8312-13318 Copyright c 213 by Annual Reviews. All rights

More information

Quantum Mechanical Models of P450 Metabolism to Guide Optimization of Metabolic Stability

Quantum Mechanical Models of P450 Metabolism to Guide Optimization of Metabolic Stability Quantum Mechanical Models of P450 Metabolism to Guide Optimization of Metabolic Stability Optibrium Webinar 2015, June 17 2015 Jonathan Tyzack, Matthew Segall, Peter Hunt Optibrium, StarDrop, Auto-Modeller

More information